The latest funding comes on top of $61.3 million in new funding the local biotech raised in April.
Image: Bill Hearl is CEO and founder of Immunomic Therapeutics in Rockville. COURTESY IMMUNOMIC THERAPEUTICS
The latest funding comes on top of $61.3 million in new funding the local biotech raised in April.
Image: Bill Hearl is CEO and founder of Immunomic Therapeutics in Rockville. COURTESY IMMUNOMIC THERAPEUTICS